LigaChem Biosciences (141080.KQ) Earnings Analysis

LigaChem Biosciences (141080.KQ) next reports earnings on 2026-08-18, consensus EPS -1,008.35092 KRW. Last quarter (2026-05-15) it missed with EPS -1,024.47786 KRW vs -365.25683 KRW est (-180.5%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E -23.87.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 141080.KQ next report earnings?

Next earnings date2026-08-18
Consensus EPS estimate-1,008.35092 KRW
Revenue estimate15.24B

141080.KQ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-15-1,024.47786 KRW-365.25683 KRW-180.5%Miss
2026-02-13-1,781.14567 KRW-1,781.14567 KRW0%Beat
2025-05-14688.34 KRW688.34 KRW0%Beat
2025-02-14-149.36015 KRWn/an/an/a
2024-11-14328 KRW106.59 KRW+207.7%Beat
2024-08-14-269 KRW130.13 KRW-306.7%Miss

Beat rate: 3/5 (60%) over reported quarters with consensus data.

141080.KQ valuation and analyst view

Trailing P/E-23.87
Trailing EPS-3,789.29893 KRW
Price / book8.00
Dividend yield0.00%
Market cap3421.67B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is LigaChem Biosciences (141080.KQ)'s next earnings date?

LigaChem Biosciences is next scheduled to report on 2026-08-18, with a consensus EPS estimate of -1008.35092 KRW and revenue estimate of 15.24B.

Did 141080.KQ beat earnings last quarter?

In its 2026-05-15 report, 141080.KQ posted EPS of -1024.47786 KRW versus a -365.25683 KRW estimate — a miss of 180.5%.

What is 141080.KQ's earnings track record?

Over the last 5 reported quarters with consensus data, 141080.KQ beat estimates 3 times (60%).

What is 141080.KQ's current P/E ratio and EPS?

141080.KQ trades at a trailing P/E of -23.87 on trailing EPS of -3789.29892974753 KRW.

What do analysts rate 141080.KQ?

141080.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.